Clinical Trial Update: Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating oral gallium maltolate for relapsed and refractory glioblastoma; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Gallium maltolate (gallium maltolate)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Glioblastoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING